D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$392M |
| 2 |
Starbucks
SBUX
|
+$370M |
| 3 |
Pfizer
PFE
|
+$338M |
| 4 |
PayPal
PYPL
|
+$320M |
| 5 |
Charles Schwab
SCHW
|
+$305M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$415M |
| 4 |
Citigroup
C
|
+$312M |
| 5 |
Booking.com
BKNG
|
+$289M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Financials | 11.39% |
| 4 | Healthcare | 11.24% |
| 5 | Energy | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2726
A10 Networks
ATEN
$1.26B
| $982K | ﹤0.01% |
70,430
+16,172
| +30% | +$225K |
|
2727
Caesarstone
CSTE
$48.4M
| $982K | ﹤0.01% |
93,373
-62,054
| -40% | -$653K |
|
|
BNFT
2728
DELISTED
Benefitfocus, Inc.
BNFT
| $982K | ﹤0.01% |
77,824
-60,253
| -44% | -$760K |
|
2729
Aurinia Pharmaceuticals
AUPH
$1.68B
| $977K | ﹤0.01% |
78,913
-109,420
| -58% | -$1.35M |
|
|
ATRS
2730
DELISTED
Antares Pharma, Inc.
ATRS
| $976K | ﹤0.01% |
+238,233
| New | +$976K |
|
2731
RPC Inc
RES
$986M
| $975K | ﹤0.01% |
91,402
+13,282
| +17% | +$142K |
|
|
MTA
2732
Metalla Royalty & Streaming
MTA
$527M
| $974K | ﹤0.01% |
137,790
+122,435
| +797% | +$865K |
|
|
WBA
2733
DELISTED
Walgreens Boots Alliance
WBA
| $971K | ﹤0.01% |
21,673
+3,107
| +17% | +$139K |
|
2734
CCC Intelligent Solutions
CCCS
$6.37B
| $970K | ﹤0.01% |
87,845
-130,731
| -60% | -$1.44M |
|
|
SCLE
2735
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
| $970K | ﹤0.01% |
98,648
-14,530
| -13% | -$143K |
|
2736
Zentalis Pharmaceuticals
ZNTL
$107M
| $967K | ﹤0.01% |
20,959
+2,867
| +16% | +$132K |
|
|
NGM
2737
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $967K | ﹤0.01% |
63,397
+3,366
| +6% | +$51.3K |
|
|
CBAY
2738
DELISTED
Cymabay Therapeutics
CBAY
| $965K | ﹤0.01% |
310,282
+63,494
| +26% | +$197K |
|
2739
Olin
OLN
$3.02B
| $963K | ﹤0.01% |
18,429
-16,241
| -47% | -$849K |
|
|
OCFT
2740
OneConnect Financial Technology
OCFT
$281M
| $962K | ﹤0.01% |
68,281
+58,284
| +583% | +$821K |
|
2741
Leslie's
LESL
$62M
| $960K | ﹤0.01% |
+49,627
| New | +$960K |
|
|
PTRA
2742
DELISTED
Proterra Inc. Common Stock
PTRA
| $956K | ﹤0.01% |
127,185
-1,168
| -0.9% | -$8.78K |
|
|
CFB
2743
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $952K | ﹤0.01% |
60,399
+42,111
| +230% | +$664K |
|
|
USX
2744
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $950K | ﹤0.01% |
244,820
+159,232
| +186% | +$618K |
|
2745
Build-A-Bear
BBW
$971M
| $949K | ﹤0.01% |
51,913
-109,170
| -68% | -$2M |
|
2746
Brown-Forman Class A
BF.A
$13.2B
| $947K | ﹤0.01% |
15,101
+5,528
| +58% | +$347K |
|
2747
Koppers
KOP
$567M
| $946K | ﹤0.01% |
34,366
+22,730
| +195% | +$626K |
|
2748
VSE Corp
VSEC
$3.4B
| $946K | ﹤0.01% |
20,530
+9,464
| +86% | +$436K |
|
|
NAPA
2749
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $944K | ﹤0.01% |
+51,910
| New | +$944K |
|
2750
BlueLinx
BXC
$617M
| $942K | ﹤0.01% |
13,104
-31,660
| -71% | -$2.28M |
|